AGC
CELUW icon

Angelo Gordon & Co’s Celularity Inc CELUW Stock Holding History

Angelo Gordon & Co’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-37,502
Closed -$413K – 180
2020
Q4 		$413K Buy
+37,502
New +$70.2K 0.04% 84

Other funds holding CELUW

LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Angelo Gordon & Co's CELUW Position: Q1 2021 in Review

Angelo Gordon & Co sold out of Celularity Inc (CELUW) in Q1 2021, closing a stake of 37,502 shares — an estimated $413K sold.

Angelo Gordon & Co first reported a position in CELUW in Q4 2020 and held it in 1 quarter. The position peaked at $413K in Q4 2020. 23 funds tracked by Wall St. Rank hold CELUW as of Q1 2021.

  • Angelo Gordon & Co reported no remaining Celularity Inc position as of Q1 2021 after selling out during the quarter.
  • Angelo Gordon & Co sold 37,502 Celularity Inc shares in Q1 2021, an estimated $413K.
  • Angelo Gordon & Co first reported a position in Celularity Inc in Q4 2020 and held it in 1 quarter.
  • Angelo Gordon & Co's Celularity Inc position peaked at $413K in Q4 2020.
  • 23 funds tracked by Wall St. Rank held Celularity Inc as of Q1 2021.

Based on Angelo Gordon & Co's 13F filing for Q1 2021, filed 17 May 2021.